SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001493152-22-032626
Filing Date
2022-11-16
Accepted
2022-11-16 16:10:34
Documents
1

Document Format Files

Seq Description Document Type Size
1 form13ga.htm SC 13G/A 78968
  Complete submission text file 0001493152-22-032626.txt   80516
Mailing Address 400 OYSTER POINT BOULEVARD SUITE 221 SOUTH SAN FRANCISCO CA 64080
Business Address 400 OYSTER POINT BOULEVARD SUITE 221 SOUTH SAN FRANCISCO CA 64080 415-505-0809
Satsuma Pharmaceuticals, Inc. (Subject) CIK: 0001692830 (see all company filings)

IRS No.: 813039831 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91126 | Film No.: 221395269
SIC: 2834 Pharmaceutical Preparations

Mailing Address 767 FIFTH AVE 12TH FLOOR NEW YORK NY 10153
Business Address 767 FIFTH AVE 12TH FLOOR NEW YORK NY 10153 917-970-1730
COMMODORE CAPITAL LP (Filed by) CIK: 0001831942 (see all company filings)

IRS No.: 832659606 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A